Yahoo posters claim the recall is in the UK.
This is from just last week regarding mfg...
Press Release Source: Cephalon, Inc.
Cephalon Transfers Manufacture of ACTIQ(R) to its Salt Lake City Facility; Formulation Change Approved for U.S. Market by FDA
Wednesday April 2, 2:36 pm ET
WEST CHESTER, Pa., April 2 /PRNewswire-FirstCall/ -- Cephalon, Inc. (Nasdaq: CEPH - News), announced today that manufacture of ACTIQ® (oral transmucosal fentanyl citrate) [C-II] for the U.S. market has been transferred from a contract manufacturer to Cephalon's recently expanded facility in Salt Lake City, Utah. The move follows the February 19, 2003 approval by the U.S. Food and Drug Administration of a new compressed powder formulation of ACTIQ for the management of breakthrough pain in cancer patients who are tolerant to opioid therapy. This formulation, which the Salt Lake City facility has manufactured for the European market since November 2000, replaces the current sugar melt formulation sold in the United States.
"The recent expansion of our Salt Lake City manufacturing capacity allows Cephalon to satisfy increasing demand for ACTIQ, while enabling us to provide the compressed powder formulation in all of our markets," said Robert Urban, Vice President for Technical Operations. "Our new production lines have been operational for several weeks and we look forward to completing this transition." |
